PharmaBio - Crunchbase Company Profile & Funding

Q: Where is PharmaBio's headquarters?

PharmaBio is located in Tokyo, Tokyo, Japan.

Q: Who invested in PharmaBio?

PharmaBio has 3 investors including Alfresa Holdings And TNP.

Q: When was the last funding round for PharmaBio?

PharmaBio closed its last funding round on obfuscated from a Corporate Round round.

Q: How much funding has PharmaBio raised to date?

PharmaBio has raised obfuscated.

Overview

PharmaBio

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

See more interactive data and historical milestones on desktop for the best experience

About PharmaBio

CB Rank

158857

PharmaBio is a healthcare company specializing in developing and manufacturing drug and regenerative medicine products.

Founded

obfuscation

Private

Corporate Round

Tokyo, Tokyo, Japan

11-50

www.pharmabio.co.jp/

Health Care

Health Diagnostics

Hospital

Medical

Funding Rounds

Corporate Round

OBF

obfuscation

Venture - Series Unknown

OBF

obfuscation

Venture - Series Unknown

OBF

obfuscation

Key People

Kaoru Miyauchi: Chairman
Hitoshi Kusano: President, CEO, and Representative Director

Details

Legal Name

Pharma Biotechnology Co., Ltd.

Also Known As

ファーマバイオ

Operating Status

Active

Company Type

For Profit

About the Company

PharmaBio is a health care company that manufacturing and development company specializing in products such as regenerative medicine, we support GCTP-compliant manufacturing with low risk and cost burden, and provide various services and products that enhance safety and quality.

Phone Number

+81 5-2569-5579

Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

PAL-222

A human allogeneic adipose tissue-derived mesenchymal stem cell sheet designed for regenerative treatment of myopic chorioretinal atrophy and neovascular age-related macular degeneration.

Contract Development and Manufacturing Services for Regenerative Medicine Products

Services for designing and operating cell processing facilities and manufacturing regenerative medicine products under contract.

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Corporate Round - PharmaBio	1	obfuscated obfuscation	Alfresa Holdings	Corporate Round
obfuscated obfuscation	Corporate Round - PharmaBio	1	obfuscated obfuscation	Alfresa Holdings	Corporate Round
obfuscated obfuscation	Corporate Round - PharmaBio	1	obfuscated obfuscation	Alfresa Holdings	Corporate Round
obfuscated obfuscation	Corporate Round - PharmaBio	1	obfuscated obfuscation	Alfresa Holdings	Corporate Round
obfuscated obfuscation	Corporate Round - PharmaBio	1	obfuscated obfuscation	Alfresa Holdings	Corporate Round

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Corporate Round - PharmaBio	1	obfuscated obfuscation	Alfresa Holdings	Corporate Round
obfuscated obfuscation	Corporate Round - PharmaBio	1	obfuscated obfuscation	Alfresa Holdings	Corporate Round
obfuscated obfuscation	Corporate Round - PharmaBio	1	obfuscated obfuscation	Alfresa Holdings	Corporate Round
obfuscated obfuscation	Corporate Round - PharmaBio	1	obfuscated obfuscation	Alfresa Holdings	Corporate Round
obfuscated obfuscation	Corporate Round - PharmaBio	1	obfuscated obfuscation	Alfresa Holdings	Corporate Round

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Alfresa Holdings	Yes	Corporate Round - PharmaBio	—
Alfresa Holdings	Yes	Corporate Round - PharmaBio	—
Alfresa Holdings	Yes	Corporate Round - PharmaBio	—
Alfresa Holdings	Yes	Corporate Round - PharmaBio	—
Alfresa Holdings	Yes	Corporate Round - PharmaBio	—